Shares of MaxCyte (LON:MXCT) opened at 83.00 on Tuesday. The company’s market cap is GBX 36.11 million. The firm has a 50-day moving average of GBX 84.56 and a 200-day moving average of GBX 82.20. MaxCyte has a 12-month low of GBX 75.00 and a 12-month high of GBX 86.38.
MaxCyte Company Profile
MaxCyte, Inc focuses on cell-based medicines. The Company’s cell modification technology, Flow electroporation, is used for discovery, development and manufacture of small molecule, biologic and cell-based therapeutics. The Company’s products include instruments, processing assemblies and insourcing services.
Receive News & Ratings for MaxCyte Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MaxCyte Inc and related companies with MarketBeat.com's FREE daily email newsletter.